- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00113178
Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter
February 23, 2011 updated by: Boston Scientific Corporation
Clinical Study to Evaluate the Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Cavo-Tricuspid Valve Isthmus-Dependent Atrial Flutter
The purpose of this study is to evaluate the safety and efficacy of right atrial intra-cardiac lesions created by transvenous catheter cryoablation in patients with atrial flutter.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Catheter ablation of arrhythmias has become an accepted alternative to pharmacologic therapy.
Cryoablation is a newer alternative to radiofrequency ablations.
This study expands the prior pilot experience with the CryoCor™ Cardiac Cryoablation System to a larger cohort of patients with atrial flutter.
Study Type
Interventional
Enrollment
160
Phase
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Symptomatic atrial flutter
Exclusion Criteria:
- Prior ablation
- Contraindication to intervention
- Poor general health
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Acute efficacy
|
Acute safety
|
Secondary Outcome Measures
Outcome Measure |
---|
Long-term safety
|
Long-term efficacy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2004
Study Completion (Actual)
June 1, 2005
Study Registration Dates
First Submitted
June 6, 2005
First Submitted That Met QC Criteria
June 6, 2005
First Posted (Estimate)
June 7, 2005
Study Record Updates
Last Update Posted (Estimate)
February 24, 2011
Last Update Submitted That Met QC Criteria
February 23, 2011
Last Verified
February 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GL-AFL-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Flutter
-
Vivek ReddyEnrolling by invitationAtrial Fibrillation and Flutter | Atrial Flutter Typical | Atrial Fibrillation, Paroxysmal or PersistentUnited States
-
University of PennsylvaniaWithdrawnTypical Atrial Flutter | Risk Factors With Future Development of Atrial FlutterUnited States
-
Angelo BivianoCompleted
-
Kaiser PermanenteActive, not recruitingAtrial Fibrillation and FlutterUnited States
-
Charles University, Czech RepublicCompleted
-
Hospital Universitario Central de AsturiasJohnson & JohnsonUnknown
-
Hangzhou Dinova EP Technology Co., LtdNot yet recruiting
-
University of ManchesterManchester University NHS Foundation TrustWithdrawn
-
Abbott Medical DevicesCompletedTypical Atrial FlutterUnited States, Canada
-
Abbott Medical DevicesCompletedTypical Atrial FlutterUnited States, Canada
Clinical Trials on Catheter-based cardiac cryoablation
-
Medtronic Cardiac Rhythm and Heart FailureCompleted
-
Medtronic Cardiac Rhythm and Heart FailureCompleted
-
Medtronic Cardiac Rhythm and Heart FailureCompletedTachycardia, Atrioventricular Nodal ReentryUnited States
-
Medtronic Cardiac Rhythm and Heart FailureCompletedParoxysmal Atrial Fibrillation (PAF)United States, Canada
-
Medtronic Cardiac Rhythm and Heart FailureRecruiting
-
Medtronic Cardiac Rhythm and Heart FailureRecruitingPersistent Atrial FibrillationUnited States, Austria, Germany, Italy, United Kingdom, Poland
-
Karolinska University HospitalCompleted
-
Uppsala University HospitalMedtronic; Swedish Heart Lung FoundationUnknownAtrial FibrillationSweden
-
Medtronic Cardiac Rhythm and Heart FailureCompletedAtrial Fibrillation | Atrial Fibrillation New OnsetUnited States
-
Klinikum-FuerthKlinikum NürnbergRecruitingSurgery--Complications | Anesthesia Complication | Cardiac Pacemaker Malfunction | ICD Malfunction | Cardiac Pacemaker Electrical InterferenceGermany